Benjamin A. Miko, MD
Ben is a third year fellow in the division of infectious diseases at Columbia University. He holds an MD from Boston University and completed his internal medicine residency training at New York Presbyterian Hospital/Columbia University Medical Center in 2009.
His research interests relate to the molecular epidemiology of community-associated Staphylococcus aureus (CA-SA). Over the past year, Ben had participated in a pilot study to evaluate the prevalnce of CA-SA colonization at an STD clinic in Baltimore, Maryland. High rates of nasal, pharyngeal, and genital colonization were found among patients presenting to the clinic with particularly high rates of the CA-SA epidemic clone USA300. Future research plans include an assessment of transmission of USA300 between discordant sexual partners, a gentical microbiome analysis of those colonized with USA300, and in vitro studies examining the adherence and transmissibility of this clone.
Viglianti GA, Lau CM, Hanley TM, Miko BA, Shlomchik MJ, Marshak-Rothstein A. Activation of autoreactive B cells by CpG dsDNA. Immunity. 2003 Dec; 19(6):837:47.
Sandora TJ, Desai R, Miko BA, Harper MB. Assessing quality indicators for pediatric community-acquired pneumonia. Am J Med Qual. 2009 Sept-Oct;24(5):419-27.
Lat A, Bhadelia N, Miko B, Furuya EY, Thompson GR 3rd. Invasive aspergillosis after pandemic (H1N1) 2009. Emerg Infect Dis. 2010 Jun;16(6):971-3.